Want to see HK:0570 full AI Analyst Report?
China Traditional Chinese Medicine Holdings Co (0570) Ratios
China Traditional Chinese Medicine Holdings Co Ratios
HK:0570's free cash flow for Q2 2026 was $607.44M. For the 2026 fiscal year, HK:0570's free cash flow was decreased by $-106.93M and operating cash flow was $714.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.29 | 2.42 | 2.12 | 1.78 | 2.08 |
| Quick Ratio | 1.81 | 1.80 | 1.48 | 1.18 | 1.50 |
| Cash Ratio | 0.52 | 0.50 | 0.32 | 0.30 | 0.33 |
| Solvency Ratio | 0.09 | 0.10 | 0.18 | 0.15 | 0.20 |
| Operating Cash Flow Ratio | 0.29 | 0.33 | 0.13 | 0.11 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 1.03 | 1.23 | 0.40 | 0.24 | 0.37 |
| Net Current Asset Value | $ 8.78B | $ 7.71B | $ 6.67B | $ 5.29B | $ 4.47B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.11 | 0.14 | 0.14 | 0.14 |
| Debt-to-Equity Ratio | 0.12 | 0.19 | 0.24 | 0.25 | 0.26 |
| Debt-to-Capital Ratio | 0.11 | 0.16 | 0.20 | 0.20 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.08 | 0.09 | 0.02 | 0.12 |
| Financial Leverage Ratio | 1.58 | 1.65 | 1.75 | 1.77 | 1.85 |
| Debt Service Coverage Ratio | 0.66 | 0.72 | 0.87 | 0.43 | 1.34 |
| Interest Coverage Ratio | -2.60 | 1.42 | 7.17 | 4.82 | 12.40 |
| Debt to Market Cap | 0.26 | 0.36 | 0.28 | 0.31 | 0.23 |
| Interest Debt Per Share | 0.52 | 0.84 | 1.06 | 1.05 | 1.05 |
| Net Debt to EBITDA | -0.96 | 0.08 | 0.84 | 0.92 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.09% | 47.59% | 51.18% | 50.32% | 62.09% |
| EBIT Margin | 3.06% | 4.55% | 7.86% | 7.42% | 14.39% |
| EBITDA Margin | 10.92% | 11.05% | 14.11% | 15.10% | 18.85% |
| Operating Profit Margin | -1.82% | 2.03% | 7.88% | 7.44% | 14.45% |
| Pretax Profit Margin | -2.50% | 0.99% | 6.76% | 5.87% | 13.23% |
| Net Profit Margin | -2.32% | 0.33% | 7.09% | 5.34% | 10.14% |
| Continuous Operations Profit Margin | -3.11% | 0.13% | 7.70% | 5.04% | 11.14% |
| Net Income Per EBT | 92.90% | 33.15% | 104.95% | 91.00% | 76.69% |
| EBT Per EBIT | 136.94% | 48.60% | 85.80% | 78.94% | 91.54% |
| Return on Assets (ROA) | -1.06% | 0.15% | 3.47% | 2.15% | 5.31% |
| Return on Equity (ROE) | -1.67% | 0.25% | 6.07% | 3.79% | 9.80% |
| Return on Capital Employed (ROCE) | -1.09% | 1.23% | 5.15% | 4.17% | 9.97% |
| Return on Invested Capital (ROIC) | -1.00% | 0.15% | 4.65% | 3.04% | 7.78% |
| Return on Tangible Assets | -1.35% | 0.20% | 4.57% | 2.91% | 7.26% |
| Earnings Yield | -3.62% | 0.49% | 7.17% | 4.84% | 9.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.70 | 1.98 | 1.98 | 1.88 | 2.28 |
| Payables Turnover | 3.47 | 3.87 | 3.23 | 3.76 | 3.72 |
| Inventory Turnover | 2.06 | 1.81 | 1.48 | 1.18 | 1.43 |
| Fixed Asset Turnover | 2.05 | 2.14 | 2.28 | 1.78 | 2.39 |
| Asset Turnover | 0.46 | 0.47 | 0.49 | 0.40 | 0.52 |
| Working Capital Turnover Ratio | 1.40 | 1.54 | 1.98 | 1.65 | 2.24 |
| Cash Conversion Cycle | 286.82 | 291.72 | 317.42 | 407.65 | 316.64 |
| Days of Sales Outstanding | 215.08 | 184.32 | 184.72 | 194.43 | 159.82 |
| Days of Inventory Outstanding | 177.05 | 201.75 | 245.85 | 310.25 | 254.81 |
| Days of Payables Outstanding | 105.31 | 94.35 | 113.15 | 97.03 | 98.00 |
| Operating Cycle | 392.13 | 386.07 | 430.57 | 504.68 | 414.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.45 | 0.51 | 0.23 | 0.22 | 0.16 |
| Free Cash Flow Per Share | 0.39 | 0.41 | 0.14 | 0.11 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 3.17 | 5.04 | 1.60 | 1.30 | 0.69 |
| Capital Expenditure Coverage Ratio | 7.04 | 5.04 | 2.39 | 2.07 | 0.91 |
| Operating Cash Flow Coverage Ratio | 0.91 | 0.64 | 0.23 | 0.22 | 0.16 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.16 | 0.06 | 0.08 | 0.04 |
| Free Cash Flow Yield | 20.70% | 18.96% | 3.79% | 3.58% | -0.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -27.65 | 202.08 | 13.95 | 20.65 | 10.97 |
| Price-to-Sales (P/S) Ratio | 0.64 | 0.66 | 0.99 | 1.10 | 1.11 |
| Price-to-Book (P/B) Ratio | 0.46 | 0.52 | 0.85 | 0.78 | 1.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.83 | 5.28 | 26.36 | 27.93 | -261.22 |
| Price-to-Operating Cash Flow Ratio | 4.14 | 4.23 | 15.34 | 14.45 | 26.64 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -2.11 | 0.19 | -0.34 | 0.72 |
| Enterprise Value Multiple | 4.91 | 6.07 | 7.85 | 8.22 | 6.51 |
| Enterprise Value | 7.90B | 11.07B | 20.08B | 17.76B | 23.37B |
| EV to EBITDA | 4.91 | 6.07 | 7.85 | 8.22 | 6.51 |
| EV to Sales | 0.54 | 0.67 | 1.11 | 1.24 | 1.23 |
| EV to Free Cash Flow | 4.04 | 5.35 | 29.51 | 31.43 | -287.94 |
| EV to Operating Cash Flow | 3.46 | 4.29 | 17.18 | 16.26 | 29.36 |
| Tangible Book Value Per Share | 3.26 | 3.14 | 2.98 | 2.70 | 2.56 |
| Shareholders’ Equity Per Share | 4.07 | 4.21 | 4.20 | 4.00 | 3.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.24 | 0.87 | -0.14 | 0.14 | 0.16 |
| Revenue Per Share | 2.93 | 3.28 | 3.60 | 2.84 | 3.78 |
| Net Income Per Share | -0.07 | 0.01 | 0.26 | 0.15 | 0.38 |
| Tax Burden | 0.93 | 0.33 | 1.05 | 0.91 | 0.77 |
| Interest Burden | -0.82 | 0.22 | 0.86 | 0.79 | 0.92 |
| Research & Development to Revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
| SG&A to Revenue | 0.41 | 0.39 | 0.06 | 0.07 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -6.19 | 15.84 | 0.95 | 1.30 | 0.32 |
Currency in CNY
